Analyze Diet

Topic:Flunixin Meglumine

Flunixin Meglumine is a non-steroidal anti-inflammatory drug (NSAID) commonly used in horses to manage pain and inflammation associated with musculoskeletal disorders, colic, and other conditions. It functions by inhibiting the enzyme cyclooxygenase, which is involved in the production of prostaglandins that mediate inflammation and pain. Flunixin Meglumine is administered through various routes, including intravenous and oral formulations, and is noted for its rapid onset of action. The pharmacokinetics, efficacy, and safety profile of Flunixin Meglumine in equine medicine are subjects of ongoing research. This page compiles peer-reviewed research studies and scholarly articles that explore the pharmacological properties, therapeutic applications, and potential side effects of Flunixin Meglumine in horses.
Selected aspects of the clinical pharmacology of visceral analgesics and gut motility modifying drugs in the horse.
Journal of veterinary internal medicine    April 1, 1988   Volume 2, Issue 2 85-91 doi: 10.1111/j.1939-1676.1988.tb02799.x
Kohn CW, Muir WW.Comparison of the visceral analgesic effects of xylazine, morphine, butorphanol, pentazocine, meperidine, dipyrone, and flunixin in a cecal distention model of colic pain indicated that xylazine produces the most relief from abdominal discomfort. Repeated administration of xylazine may reduce visceral pain so effectively that the seriousness of abdominal disease is obscured. Xylazine decreased propulsive motility in the jejunum and pelvic flexure of healthy ponies. Morphine and butorphanol also gave relief from visceral pain in the cecal distention model. Morphine may inhibit colonic, and buto...
Septic periorchitis in a horse.
Journal of the American Veterinary Medical Association    February 1, 1988   Volume 192, Issue 3 363-364 
Belknap J, Arden W, Yamini B.A 2-month-old Standard-bred colt with signs of abdominal pain and large scrotum was found to have septic periorchitis involving the right testis. Surgical exploration of the abdomen and scrotum was performed; the colt was then castrated. Actinobacillus equuli was isolated from specimens obtained at surgery. The colt was treated with broad-spectrum antibiotics and flunixin meglumine after surgery, and fully recovered. The clinical signs of periorchitis in the colt were similar to an inguinal/scrotal hernia.
Chronic flunixin meglumine therapy in foals.
American journal of veterinary research    January 1, 1988   Volume 49, Issue 1 7-12 
Traub-Dargatz JL, Bertone JJ, Gould DH, Wrigley RH, Weiser MG, Forney SD.Effects of a therapeutic dose of flunixin meglumine on gastric mucosa of horse foals were determined by endoscopy, double-contrast radiography, and gross and histologic examinations. Foals were administered 1.1 mg of flunixin meglumine/kg of body weight, PO/day for 30 days in an encapsulated form that was divided into 2 doses/day (group 1; n = 3) or by IM injection once a day (group 2; n = 7). Three control foals (group 3; n = 3) were administered capsules (n = 1) containing dextrose powder or IM injections (n = 2) of vehicle solution without flunixin meglumine. All 3 groups-1 foals given flun...
Identification of a flunixin metabolite in the horse by gas chromatography-mass spectrometry.
Journal of chromatography    December 25, 1987   Volume 423 123-130 doi: 10.1016/0378-4347(87)80334-1
Jaussaud P, Courtot D, Guyot JL, Paris J.The main metabolite of flunixin, a hydroxylated product, has been identified by gas chromatography-mass spectrometry and 1H NMR spectroscopy in equine urine and plasma. The method also permits the qualitative monitoring of the urinary elimination of the drug and its metabolite. The two products are detected up to 175 and 54 h, respectively, after a single intravenous administration at the dose of 1 mg/kg. Simultaneous detection of the two compounds increases the reliability of anti-doping control analysis.
Pancytopenia caused by bone marrow aplasia in a horse.
Journal of the American Veterinary Medical Association    December 1, 1987   Volume 191, Issue 11 1462-1464 
Lavoie JP, Morris DD, Zinkl JG, Lloyd K, Divers TJ.Pancytopenia was evaluated in a mature Quarter Horse gelding. A diagnosis of bone marrow aplasia was made on the basis of bone marrow hypocellularity. History of drugs administered included penicillin, oxytetracycline, trimethoprim-sulfadiazine, phenylbutazone, dipyrone, flunixin meglumine, and isoxsuprine. Clinical remission was observed after treatment with glucocorticoids, androgens, and broad-spectrum antimicrobials.
Pharmacological modulation of postprandial colonic motor activity in the pony.
Journal of veterinary pharmacology and therapeutics    December 1, 1987   Volume 10, Issue 4 273-282 doi: 10.1111/j.1365-2885.1987.tb00102.x
Roger T, Ruckebusch Y.The contractile activity of the equine large intestine exhibited a biphasic response to feeding: enhancement of migrating complexes passing along the colon and an increase of 50% in cyclic variations in smooth muscle at intervals of 20 min on the left ventral colon for a period of 5 to 7 h postfeeding. The cholinergic agonist, bethanechol (50 micrograms/kg subcutaneously), induced both the migrating complexes and the cyclic variations at intervals of 10-15 min. In contrast, the intra-arterial infusion of PGF2 alpha (3 micrograms/kg/min) increased the contractile activity during infusion, but w...
Evaluation of the potential for interference by dimethyl sulfoxide (DMSO) in drug detection in racing animals.
Journal of veterinary pharmacology and therapeutics    December 1, 1987   Volume 10, Issue 4 298-304 doi: 10.1111/j.1365-2885.1987.tb00105.x
Craig AM, Blythe LL, Appell LH, Slizeski ML.Dimethyl sulfoxide (DMSO) had been postulated to be a 'masking agent' when used concurrently with therapeutic or prohibited drugs in racing animals. Eight drugs (flunixin, furosemide, caffeine, apomorphine, phenylbutazone, lidocaine, cocaine, and acepromazine maleate) were administered to six horses singly and with concurrent intravenous DMSO. Urine samples were analyzed for the presence of the drugs and/or their metabolites by thin layer chromatography. Direct comparison of thin layer chromatograms of extracts of positive urine samples with and without DMSO verified that DMSO did not interfer...
Management of twin conceptuses by manual embryonic reduction: comparison of two techniques and three hormone treatments.
American journal of veterinary research    November 1, 1987   Volume 48, Issue 11 1594-1599 
Pascoe DR, Pascoe RR, Hughes JP, Stabenfeldt GH, Kindahl H.One hundred mares carrying twin conceptuses between gestation days (GD) 12 and 30 were assigned to 4 groups. Group-1 mares (n = 20) were given a placebo (sterile saline solution, IV, and sesame oil, IM). Group-2 mares (n = 32) were given a single dose of progesterone (625 mg, IM) in sesame oil. Group-3 mares (n = 28) were given multiple progesterone treatments (625 mg, IM) at 6-day intervals until GD 42. Group-4 mares (n = 20) were given a single treatment of flunixin meglumine (500 mg, IV) and progesterone (625 mg, IM). Each group was further assigned to equal subgroups A and B according to t...
Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin.
The British veterinary journal    September 1, 1987   Volume 143, Issue 5 462-476 doi: 10.1016/0007-1935(87)90024-8
Lees P, Ewins CP, Taylor JB, Sedgwick AD.No abstract available
Ultrastructure of equine endothelial cells exposed to endotoxin and flunixin meglumine and equine neutrophils.
American journal of veterinary research    September 1, 1987   Volume 48, Issue 9 1363-1366 
Turek JJ, Lamar CH, Fessler JF, Bottoms GD.An in vitro system of cultured equine endothelial cells was evaluated as a model for endotoxin (ET) exposure in the horse. Primary cell lines from pulmonary vessels and aortas were cultured from tissues of 6 horses. Effects of ET alone with and without serum and in combination with the cyclo-oxygenase inhibitor flunixin meglumine and isolated equine neutrophils were evaluated by transmission electron microscopy. Cells plus serum were incubated with 10, 25, 50, or 100 micrograms of ET/ml of incubation medium for 1, 3, 8, or 24 hours. Cells without serum were cultured for 1 and 3 hours. Flunixin...
Measurement of flunixin in equine inflammatory exudate and plasma by high performance liquid chromatography.
Equine veterinary journal    July 1, 1987   Volume 19, Issue 4 303-306 doi: 10.1111/j.2042-3306.1987.tb01416.x
Higgins AJ, Lees P, Sharma SC, Taylor JB.An accurate and reliable method for the separation of flunixin from, and measurement in, equine inflammatory exudate and plasma by high performance liquid chromatography has been developed. Flunixin can be detected in concentrations as low as 0.05 micrograms/ml using an ultraviolet spectrophotometric detector at 285 nm. Samples were acidified with 2M hydrochloric acid and extracted with dichloromethane. The extract was evaporated and reconstituted in acetonitrile. Iminodibenzyl was used as internal standard. The mean recovery of flunixin from plasma was 97.6 +/- 3.9 per cent. Particular advant...
Equine endotoxemia: cardiovascular, eicosanoid, hematologic, blood chemical, and plasma enzyme alterations.
American journal of veterinary research    July 1, 1987   Volume 48, Issue 7 1150-1156 
Ward DS, Fessler JF, Bottoms GD, Turek J.Ponies with electromagnetic blood flow transducers implanted around the main pulmonary and left main coronary arteries, were used to evaluate effects of chronic sublethal endotoxin on cardiac output (CO), stroke volume, and left coronary blood flow (LCBF). Plasma thromboxane (TX), as indicated by TXB2, prostacyclin as indicated by 6-keto-prostaglandin (PG) F1 alpha, and hematologic and blood chemical values also were evaluated. Over 24 hours, 2 groups of ponies were given progressively increasing IV and intraperitoneal doses of Escherichia coli lipopolysaccharide (LPS) at 0, 6, 12, and 18 hour...
Actions of non-steroidal anti-inflammatory drugs on equine leucocyte movement in vitro.
Journal of veterinary pharmacology and therapeutics    June 1, 1987   Volume 10, Issue 2 150-159 doi: 10.1111/j.1365-2885.1987.tb00092.x
Dawson J, Lees P, Sedgwick AD.The direct effects of four non-steroidal anti-inflammatory drugs (NSAIDs) on equine polymorphonuclear (PMN) and mononuclear (MN) leucocyte movement were investigated using two in vitro assay systems. The Boyden chamber microfilter technique measures both chemokinetic and chemotactic locomotion, and the agarose microdroplet assay measures solely chemokinesis. Zymosan-activated plasma (ZAP) and the synthetic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) were used as standard chemoattractants for PMN and MN leucocytes, respectively. The actions of six concentrations of each NSAID, indome...
Effects of multiple low doses of flunixin meglumine on repeated endotoxin challenge in the horse.
Prostaglandins, leukotrienes, and medicine    May 1, 1987   Volume 27, Issue 2-3 169-181 doi: 10.1016/0262-1746(87)90069-2
Semrad SD, Moore JN.Previous work has shown repeated low doses of flunixin meglumine (FM) inhibit thromboxane production in normal horses. Enhanced concentrations of thromboxane in serum occurred after the drug therapy was discontinued. Our study was performed to evaluate the effects of low doses of FM in horses repeatedly challenged with endotoxin. Group I horses received E. coli endotoxin (0.1 microgram/kg IV) at 0 and 90 h. Group II horses received endotoxin and were also treated with FM (0.25 mg/kg IV) at 2, 10, 18, 26, 34, and 42 h after the initial administration of endotoxin. Clinical signs of endotoxemia ...
Low dose flunixin meglumine: effects on eicosanoid production and clinical signs induced by experimental endotoxaemia in horses.
Equine veterinary journal    May 1, 1987   Volume 19, Issue 3 201-206 doi: 10.1111/j.2042-3306.1987.tb01380.x
Semrad SD, Hardee GE, Hardee MM, Moore JN.The efficacy of low doses of flunixin meglumine in reducing eicosanoid generation and clinical signs in response to experimentally induced endotoxaemia was investigated. Thromboxane B2 and 6-keto-prostaglandin F1 alpha were measured in serum and plasma by radioimmunoassay. Plasma flunixin concentrations were determined by high performance liquid chromatography and pharmacokinetic parameters derived non-compartmentally. In horses administered flunixin meglumine before endotoxin challenge, a significant suppression in plasma thromboxane B2 and 6-keto-prostaglandin F1 alpha generation was observe...
Endotoxin-induced hemodynamic and prostaglandin changes in ponies: effects of flunixin meglumine, dexamethasone, and prednisolone.
Circulatory shock    January 1, 1987   Volume 23, Issue 4 231-240 
Templeton CB, Bottoms GD, Fessler JF, Ewert KM, Roesel OF, Johnson MA, Latshaw HS.Shock was induced in four groups of anesthetized ponies with an intravenous injection of Escherichia coli endotoxin [125 micrograms/kg]. Five minutes after endotoxin injection, the ponies were given no treatment (group A), flunixin meglumine (FM:1.1 mg/kg) (group B), dexamethasone (2 mg/kg) (group C), or prednisolone (10 mg/kg) (group D). Additionally, FM was given every 3 hours, and the steroids were given at 3, 9, and 24 hours following endotoxin. Hemodynamic measurements were made during the 4-hour anesthetic period. Blood samples were collected for the analysis of prostaglandins, blood che...
Flunixin meglumine: quantitative determination in and effects on composition of equine inflammatory exudate.
The British veterinary journal    March 1, 1986   Volume 142, Issue 2 163-169 doi: 10.1016/0007-1935(86)90093-X
Higgins AJ, Lees P, Taylor JB, Ewins CP.No abstract available
Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
Research in veterinary science    March 1, 1986   Volume 40, Issue 2 152-156 
Hardee MM, Moore JN, Hardee GE.The efficacy of three agents which alter the metabolism of arachidonic acid was investigated in normal, conscious horses. A dose response evaluation was made of flunixin meglumine and phenylbutazone, two cyclo-oxygenase inhibitors, and of a selective thromboxane synthetase inhibitor, UK-38,485. Radioimmunoassay of thromboxane B2 (TxB2) and 6-keto prostaglandin F1 alpha (PGF1 alpha) was used to assess the concentrations of thromboxane A2 (TxA2) and prostacyclin (PGI2) respectively, in serum. Flunixin was the most potent inhibitor of serum TxB2 and 6-keto PGF1 alpha production. UK-38,485 also de...
[Flunixin and its use in horses].
Annales de recherches veterinaires. Annals of veterinary research    January 1, 1986   Volume 17, Issue 4 353-362 
Jaussaud P.Flunixin is a non-steroidal anti-inflammatory agent, with a potent analgesic activity and a slight toxicity. It is largely used in horses, in the form of meglumine salt, for the treatment of inflammatory diseases or colics, and often identified in dopage cases. Physical and chemical properties of the drug, its pharmacological and toxicological properties, and its use in equine species are depicted.
Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor.
American journal of veterinary research    January 1, 1986   Volume 47, Issue 1 110-113 
Moore JN, Hardee MM, Hardee GE.Two cyclooxygenase inhibitors (flunixin meglumine and phenylbutazone) and a selective thromboxane synthetase inhibitor were assessed in the management of experimental equine endotoxemia. Drugs or saline solution were administered to 16 horses 15 minutes before administration of a sublethal dose of endotoxin (Escherichia coli 055:B5). Plasma concentrations of thromboxane B2 (TxB2), prostacyclin (6-keto PGF1 alpha), plasma lactate, and hematologic values and clinical appearance were monitored for 3 hours after endotoxin administration. Pretreatment with flunixin meglumine (1 mg/kg of body weight...
Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses.
American journal of veterinary research    December 1, 1985   Volume 46, Issue 12 2474-2479 
Semrad SD, Hardee GE, Hardee MM, Moore JN.The pharmacokinetics and inhibition of prostaglandin synthesis in conscious horses given various dosages of flunixin meglumine were studied. Plasma concentrations of flunixin were measured by high-performance liquid chromatography, and serum thromboxane B2 and 6-keto prostaglandin F1 alpha were quantitated by radioimmunoassay. Within the dosage range studied, linear pharmacokinetics were achieved. After IV administration of flunixin (1.1 mg/kg, 0.25 mg/kg, 0.1 mg/kg), significant suppression of serum thromboxane generation persisted for 12, 4, and 3 hours, respectively. Repeated administration...
Effects of flunixin meglumine on cardiopulmonary responses to endotoxin in ponies.
Journal of applied physiology (Bethesda, Md. : 1985)    November 1, 1985   Volume 59, Issue 5 1464-1471 doi: 10.1152/jappl.1985.59.5.1464
Olson NC, Meyer RE, Anderson DL.The effects of endotoxemia on cardiopulmonary parameters, before and after cyclooxygenase blockade, were determined in anesthetized ponies spontaneously breathing a mixture of halothane and 100% O2. Escherichia coli endotoxin was infused intravenously at 20 micrograms/kg for 1 h followed by 10 micrograms X kg-1 X h-1 the subsequent 4 h. By 15 min endotoxin increased mean pulmonary arterial pressure (Ppa), pulmonary vascular resistance (PVR), and alveolar dead space ventilation (VDA/VT), and these were followed by a return to base-line values by 30 min. A second increase in PVR occurred by 5 h ...
Effects of flunixin meglumine on blood pressure and fluid compartment volume changes in ponies given endotoxin.
American journal of veterinary research    July 1, 1985   Volume 46, Issue 7 1540-1544 
Dunkle NJ, Bottoms GD, Fessler JF, Knox K, Roesel OF.A study was conducted to determine whether body fluids undergo a net shift from one compartment to another during endotoxin-induced shock in the pony, and whether flunixin meglumine alters these endotoxin-induced changes in the volumes of body fluid compartments. Total blood, RBC, and plasma volumes were determined, using 51Cr-labeled RBC and PCV that were corrected for trapped plasma. Total body water was measured by distribution of 3HOH. Arterial blood pressure was measured directly, using a blood pressure transducer. Treatment (flunixin meglumine, 1.1 mg/kg of body weight) was given to 6 of...
Clinical pharmacology and therapeutic uses of non-steroidal anti-inflammatory drugs in the horse.
Equine veterinary journal    March 1, 1985   Volume 17, Issue 2 83-96 doi: 10.1111/j.2042-3306.1985.tb02056.x
Lees P, Higgins AJ.Weak organic acids possessing anti-inflammatory, analgesic and antipyretic properties--commonly known as aspirin-like drugs--have been used in equine medicine for almost 100 years. These non-steroidal anti-inflammatory drugs (NSAIDs) may be classified chemically into two groups; the enolic acids such as phenylbutazone and carboxylic acids like flunixin, meclofenamate and naproxen. All NSAIDs have similar and possibly identical modes of action accounting for both their therapeutic and their toxic effects. They block some part of the cyclo-oxygenase enzyme pathway and thereby suppress the synthe...
Flunixin meglumine attenuation of endotoxin-induced damage to the cardiopulmonary vascular endothelium of the pony.
American journal of veterinary research    March 1, 1985   Volume 46, Issue 3 591-596 
Turek JJ, Templeton CB, Bottoms GD, Fessler JF.Endotoxic shock was induced in 5 ponies by intraperitoneal injections of 20, 40, 60, 80, and 80 micrograms of Escherichia coli endotoxin (LPS)/kg of body weight at 0, 6, 12, 18, and 24 hours, respectively. At 24 hours, the ponies also were given 20 micrograms of LPS/kg via catheter in the left ventricle of the heart. A 2nd group of 4 ponies was given 1.1 mg of flunixin meglumine (FM)/kg, IV, at 6, 12, 18, and 24 hours just before the corresponding LPS injection. Two hours after the 24-hour LPS injection, the ponies in both groups were anesthetized, the lungs were perfused with fixative, and po...
Effects of repeated endotoxin injections on prostanoids, hemodynamics, endothelial cells, and survival in ponies.
Circulatory shock    January 1, 1985   Volume 16, Issue 3 253-264 
Templeton CB, Bottoms GD, Fessler JF, Turek JJ, Boon GD.The objectives of this study were to determine the pathophysiological effects of increasing amounts of endotoxin administered intraperitoneally (IP) for 24 hr at which time an intravenous (IV) injection of endotoxin was given. The ability of flunixin meglumine (FM), a nonsteroidal antiinflammatory drug with antiprostaglandin activity, to provide protective effects was also determined. Eight ponies were divided into two groups of four ponies each; one group (untreated) received endotoxin only and the other group (treated) received endotoxin while being treated with flunixin. Hemodynamic and ser...
Endotoxin-induced eicosanoid production by equine vascular endothelial cells and neutrophils.
Circulatory shock    January 1, 1985   Volume 15, Issue 3 155-162 
Bottoms GD, Johnson MA, Lamar CH, Fessler JF, Turek JJ.Dispersed equine vascular endothelial cells grown in tissue culture, and freshly isolated neutrophils were used to determine direct effects of endotoxin on cyclooxygenase and lipoxygenase products. Endothelial cells (10(7)/ml) or neutrophils (2 X 10(6)/ml) were incubated with (a) buffer, (b) endotoxin (10 micrograms/ml), (c) endotoxin + flunixin meglumine (10 micrograms/ml), or (d) calcium ionophore, A23187 (10 micrograms/ml). Thromboxane (TxB2), prostacyclin (6-keto-PGF1 alpha), and leukotriene C4 (LTC4) were determined in the incubation fluid by radioimmunoassay. Thromboxane and prostacyclin...
Endotoxin-induced hematologic and blood chemical changes in ponies: effects of flunixin meglumine, dexamethasone, and prednisolone.
American journal of veterinary research    January 1, 1985   Volume 46, Issue 1 24-30 
Ewert KM, Fessler JF, Templeton CB, Bottoms GD, Latshaw HS, Johnson MA.To evaluate the effect of certain drugs on hematologic changes, blood chemical values, and survival in endotoxin shock, anesthetized ponies were given (IV) endotoxin (Escherichia coli O55:B5) and then treated as follows: Group A ponies--given a saline infusion at 5 minutes and at 3 hours after they were given endotoxin; group B ponies--given flunixin meglumine at 5 minutes and at 3, 6, 9, and 24 hours after they were given endotoxin; group C ponies--treated with dexamethasone; and group D ponies--treated with prednisolone at 5 minutes and at 3, 9, and 24 hours after they were given endotoxin. ...
Flunixin inhibits prostaglandin E2 production in equine inflammation.
Research in veterinary science    November 1, 1984   Volume 37, Issue 3 347-349 
Lees P, Higgins AJ.A model of acute inflammation was used in a cross-over study in Welsh mountain ponies to assess the actions of flunixin meglumine on selected components of a localised inflammatory reaction induced by injecting 0.5 ml of a 2 per cent carrageenin solution into subcutaneously implanted tissue cages. Samples of exudate were harvested at predetermined times between three and 48 hours. Increases in leucocyte numbers and protein concentration were not prevented by flunixin treatment. Prostaglandin E2-like activity was present in exudates from untreated ponies with the highest mean concentration occu...
Cautious use of flunixin advocated.
The Veterinary record    July 14, 1984   Volume 115, Issue 2 45 doi: 10.1136/vr.115.2.45-b
Webbon PM, Woolliscroft GJ.No abstract available